Annual Total Assets
$8.26 M
-$56.67 M-87.28%
December 31, 2023
Summary
- As of February 24, 2025, TCRT annual total assets is $8.26 million, with the most recent change of -$56.67 million (-87.28%) on December 31, 2023.
- During the last 3 years, TCRT annual total assets has fallen by -$138.08 million (-94.35%).
- TCRT annual total assets is now -94.62% below its all-time high of $153.72 million, reached on December 31, 2015.
Performance
TCRT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$3.55 M
-$1.13 M-24.11%
September 30, 2024
Summary
- As of February 24, 2025, TCRT quarterly total assets is $3.55 million, with the most recent change of -$1.13 million (-24.11%) on September 30, 2024.
- Over the past year, TCRT quarterly total assets has stayed the same.
- TCRT quarterly total assets is now -98.21% below its all-time high of $198.28 million, reached on March 31, 2020.
Performance
TCRT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
TCRT Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.3% | 0.0% |
| 3 y3 years | -94.3% | -96.9% |
| 5 y5 years | -91.3% | -97.9% |
TCRT Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.3% | at low | -96.3% | at low |
| 5 y | 5-year | -94.3% | at low | -98.2% | at low |
| alltime | all time | -94.6% | -100.0% | -98.2% | -100.0% |
Alaunos Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.55 M(-24.1%) |
| Jun 2024 | - | $4.68 M(-22.5%) |
| Mar 2024 | - | $6.04 M(-26.9%) |
| Dec 2023 | $8.26 M(-87.3%) | $8.26 M(-57.5%) |
| Sep 2023 | - | $19.44 M(-30.4%) |
| Jun 2023 | - | $27.93 M(-42.6%) |
| Mar 2023 | - | $48.64 M(-25.1%) |
| Dec 2022 | $64.94 M(-31.5%) | $64.94 M(-3.6%) |
| Sep 2022 | - | $67.34 M(-8.9%) |
| Jun 2022 | - | $73.93 M(-13.0%) |
| Mar 2022 | - | $84.99 M(-10.4%) |
| Dec 2021 | $94.86 M(-35.2%) | $94.86 M(-16.6%) |
| Sep 2021 | - | $113.76 M(+6.6%) |
| Jun 2021 | - | $106.77 M(-16.9%) |
| Mar 2021 | - | $128.47 M(-12.2%) |
| Dec 2020 | $146.34 M(+34.1%) | $146.34 M(-11.8%) |
| Sep 2020 | - | $165.89 M(-8.7%) |
| Jun 2020 | - | $181.68 M(-8.4%) |
| Mar 2020 | - | $198.28 M(+81.7%) |
| Dec 2019 | $109.11 M(+14.8%) | $109.11 M(-7.5%) |
| Sep 2019 | - | $117.95 M(+61.2%) |
| Jun 2019 | - | $73.17 M(-12.4%) |
| Mar 2019 | - | $83.50 M(-12.1%) |
| Dec 2018 | $95.05 M(-10.0%) | $95.05 M(+42.3%) |
| Sep 2018 | - | $66.80 M(-12.5%) |
| Jun 2018 | - | $76.38 M(-12.7%) |
| Mar 2018 | - | $87.46 M(-17.2%) |
| Dec 2017 | $105.61 M(-0.7%) | $105.61 M(-9.4%) |
| Sep 2017 | - | $116.56 M(-8.1%) |
| Jun 2017 | - | $126.81 M(+34.2%) |
| Mar 2017 | - | $94.49 M(-11.1%) |
| Dec 2016 | $106.35 M(-30.8%) | $106.35 M(-9.2%) |
| Sep 2016 | - | $117.12 M(-8.5%) |
| Jun 2016 | - | $128.01 M(-9.6%) |
| Mar 2016 | - | $141.68 M(-7.8%) |
| Dec 2015 | $153.72 M(+239.8%) | $153.72 M(-11.3%) |
| Sep 2015 | - | $173.36 M(+39.8%) |
| Jun 2015 | - | $124.04 M(-5.8%) |
| Mar 2015 | - | $131.65 M(+191.0%) |
| Dec 2014 | $45.24 M(-37.0%) | $45.24 M(-7.9%) |
| Sep 2014 | - | $49.11 M(-11.3%) |
| Jun 2014 | - | $55.35 M(-12.6%) |
| Mar 2014 | - | $63.33 M(-11.7%) |
| Dec 2013 | $71.75 M(-14.0%) | $71.75 M(+143.4%) |
| Sep 2013 | - | $29.48 M(-35.4%) |
| Jun 2013 | - | $45.60 M(-28.0%) |
| Mar 2013 | - | $63.35 M(-24.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $83.40 M(-22.9%) | $83.40 M(-21.0%) |
| Sep 2012 | - | $105.64 M(-13.7%) |
| Jun 2012 | - | $122.38 M(-13.1%) |
| Mar 2012 | - | $140.87 M(+30.3%) |
| Dec 2011 | $108.11 M(+75.7%) | $108.11 M(-11.6%) |
| Sep 2011 | - | $122.28 M(-7.9%) |
| Jun 2011 | - | $132.82 M(+1.5%) |
| Mar 2011 | - | $130.86 M(+112.7%) |
| Dec 2010 | $61.52 M(+23.7%) | $61.52 M(-8.8%) |
| Sep 2010 | - | $67.45 M(-9.4%) |
| Jun 2010 | - | $74.46 M(+62.4%) |
| Mar 2010 | - | $45.84 M(-7.8%) |
| Dec 2009 | $49.74 M(+295.6%) | $49.74 M(+513.8%) |
| Sep 2009 | - | $8.10 M(+49.2%) |
| Jun 2009 | - | $5.43 M(-31.0%) |
| Mar 2009 | - | $7.87 M(-37.4%) |
| Dec 2008 | $12.57 M(-65.8%) | $12.57 M(-25.2%) |
| Sep 2008 | - | $16.81 M(-25.1%) |
| Jun 2008 | - | $22.46 M(-22.6%) |
| Mar 2008 | - | $29.00 M(-21.0%) |
| Dec 2007 | $36.73 M(+24.4%) | $36.73 M(-14.2%) |
| Sep 2007 | - | $42.80 M(-11.8%) |
| Jun 2007 | - | $48.52 M(-10.5%) |
| Mar 2007 | - | $54.19 M(+83.6%) |
| Dec 2006 | $29.51 M(+210.9%) | $29.51 M(-16.4%) |
| Sep 2006 | - | $35.29 M(-6.6%) |
| Jun 2006 | - | $37.78 M(+498.9%) |
| Mar 2006 | - | $6.31 M(-33.5%) |
| Dec 2005 | $9.49 M(+556.9%) | $9.49 M(-16.1%) |
| Sep 2005 | - | $11.31 M(>+9900.0%) |
| Jun 2005 | - | $1100.00(+1000.0%) |
| Mar 2005 | - | $100.00(-100.0%) |
| Dec 2004 | $1.45 M(>+9900.0%) | $1.45 M(>+9900.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(-100.0%) |
| Mar 2004 | - | $4600.00(>+9900.0%) |
| Dec 2003 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(-100.0%) |
| Jun 2003 | - | $200.00(-98.0%) |
| Mar 2003 | - | $10.20 K(+1940.0%) |
| Dec 2002 | $500.00(-82.8%) | $500.00(-28.6%) |
| Sep 2002 | - | $700.00(-56.3%) |
| Jun 2002 | - | $1600.00(-73.8%) |
| Mar 2002 | - | $6100.00(+110.3%) |
| Dec 2001 | $2900.00 | $2900.00(-34.1%) |
| Sep 2001 | - | $4400.00(-56.9%) |
| Jun 2001 | - | $10.20 K |
FAQ
- What is Alaunos Therapeutics annual total assets?
- What is the all time high annual total assets for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual total assets year-on-year change?
- What is Alaunos Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly total assets year-on-year change?
What is Alaunos Therapeutics annual total assets?
The current annual total assets of TCRT is $8.26 M
What is the all time high annual total assets for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total assets is $153.72 M
What is Alaunos Therapeutics annual total assets year-on-year change?
Over the past year, TCRT annual total assets has changed by -$56.67 M (-87.28%)
What is Alaunos Therapeutics quarterly total assets?
The current quarterly total assets of TCRT is $3.55 M
What is the all time high quarterly total assets for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total assets is $198.28 M
What is Alaunos Therapeutics quarterly total assets year-on-year change?
Over the past year, TCRT quarterly total assets has changed by $0.00 (0.00%)